Pharmafile Logo
Pharmafocus logo
Advanced Search

mergers

Showing 11 posts of 26 posts found.

Allergan

2015’s top five mergers and acquisitions in a record-breaking year

October 19, 2015
Sales and Marketing Deals, acquisitions, mergers, pharma, takeovers

A new report from analysts MergerMarket reveals that mergers and acquisitions so far in 2015 have surpassed the same 2014 …

Feature
Mylan building

Mylan to relaunch $27.1bn hostile takeover of Perrigo

September 10, 2015
Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover

Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …

News
Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015
Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …

News
Celgene

Celgene to acquire Receptos in $7.2bn deal

July 15, 2015
Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis

Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …

News
6127242068_23c80ef94f_z

Pharma dominates global M&A activity

July 10, 2015
Sales and Marketing M&A, MA, acquisitions, mergers, takeovers

Mergers and acquisitions in the pharma, medical and biotech sectors have hit the highest levels in nearly 15 years, a …

News
Deopmed logo

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …

News
Valeant image

Valeant to buy Salix in $14.5 billion move

February 23, 2015
Sales and Marketing Deals, Heptares, Valeant, mergers, salix, sosei

Valeant has agreed a deal to acquire US-based speciality manufacturer of gastrointestinal drugs Salix in a move worth around $14.5 …

News
Abbvie image

AbbVie reconsiders Shire deal over tax laws

October 15, 2014
Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

News
Boehringer image

Boehringer to slash 600 jobs in native Germany

September 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff

Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …

News
talent_pipeline

Hold your horses: M&A is about talent, not just pipelines

November 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent

The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …

Feature

Pressure on pharma M&A

January 7, 2013
Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers

The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026